Showing results (251-260 of 287) with videos related to

Sort By:
Pageof 29
Synapse (New York, N.Y.)|April 1, 1995
Lipophilic metabolite of [123I]beta-CIT in human plasma may obstruct quantitation of the dopamine transporterK A Bergström, C Halldin, J T Kuikka, et al.
Nuclear Medicine and Biology|April 1, 1993
[11C] beta-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigationsL Müller, C Halldin, L Farde, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 1, 1994
Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissueS Brené, N Lindefors, M Ehrlich, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1984
Clinical evaluation of sulpiride in schizophrenic patients--a double-blind comparison with chlorpromazineC Härnryd, L Bjerkenstedt, K Björk, et al.
Alcoholism, Clinical and Experimental Research|February 1, 1997
Tyrosine hydroxylase and dopamine D4 receptor allelic distribution in Scandinavian chronic alcoholicsT Geijer, E Jönsson, J Neiman, et al.
Nuclear Medicine and Biology|September 3, 1999
Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporterC Lundkvist, C Loc'h, C Halldin, et al.
Nuclear Medicine and Biology|June 25, 1998
Toxicity, mutagenicity, and behavioral effects of beta-CIT, a ligand for dopamine transporter exploration by SPECTP Emond, L Farde, S Chalon, et al.
Acta Neurologica Scandinavica|December 4, 2002
PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjectsB Gulyás, C Halldin, J Sandell, et al.
Pageof 29